Searched for
GLAND PHARMA FY26 EARNINGS
Two Trades for Today: An auto sector major for a 6.25% upmove, a mid-cap pharma stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...- Explained: Why Tata Elxsi shares crashed 7% after KPIT Tech’s Q1 revenue, profit guidance warningTata Elxsi shares fell sharply on Wednesday after rival KPIT Technologies warned of weaker-than-expected Q1FY27 revenue and margins due to ...
- Why KPIT Tech shares crashed 17% today: The BMW & Volkswagen connection explainedKPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...
- Only 1/5th the size of NSE? Why Jefferies predicts 27% upside for this near-monopoly stockJefferies has initiated coverage on MCX with a Buy rating and a target price of Rs 3,600, implying 27% upside. The brokerage expects strong...
- Ola Electric doubles QoQ growth in Q1 FY26; June vehicle registrations at 16,144 unitsOla Electric witnessed a significant surge in electric two-wheeler registrations during the April-June quarter, nearly doubling from the pr...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities declined for a second session as investors stayed cautious despite easing geopolitical tensions. Sensex lost nearly 250 poi...
- MSC-Adani deal: Vizhinjam port can generate Rs 1,410 crore EBITDA, says Axis CapitalAxis Capital expects Vizhinjam port to become a major earnings driver for Adani Ports & SEZ, estimating it could generate around Rs 1,410 c...
- Motilal Oswal initiates coverage on Tata Capital, gives target price and re-rating triggersMotilal Oswal has initiated coverage on Tata Capital with a 'Neutral' rating and a target price of Rs 390, implying an 8% upside from curre...
- MGL rides PNG adoption wave, analysts see further upsideMahanagar Gas shares have surged on government's push for piped natural gas adoption, aiming for a 20% customer base increase. This move is...
- Espire Hospitality posts revenue of Rs 141 crore for FY26, PAT at Rs 8 croreEspire Hospitality has achieved a landmark financial year 2026, reporting Rs 141 crore in revenue, a 17% increase, and Rs 8 crore in profit...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- PayU India posts first full-year operating profit in FY26; revenue rises 13%During the second half of FY26, PayU India also exited certain "negative margin portfolios", impacting its sequential revenue growth. In th...
- 2 years, zero returns: Is it time for Nifty investors to be fearful or greedy?Nifty investors face two years of flat returns, mirroring past periods that historically led to significant market recoveries. Data shows t...
- ITC's business with BAT grows 10% to Rs 1,587 crore in FY26, but dividend payout falls 9%ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...
- NSE IPO to value exchange at Rs 5 lakh crore? 2 scenarios every investor should watchNSE's proposed IPO could value the exchange at around Rs 5 lakh crore, making it one of India's most valuable listed financial institutions...
- ITC CMD total remuneration slips 6.8% to Rs 23.91 crore in FY26ITC Chairman and Managing Director Sanjiv Puri's total pay saw a 6.8% dip to Rs 23.91 crore in FY26, primarily due to lower performance bon...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- Do taxpayers need to file two ITRs for FY 25-26 income? I-T Department explainsAY 26-27 and TY 26-27: Confusion surrounding the new Income Tax Act, 2025, and its transition from Assessment Year (AY) to Tax Year (TY) is...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Load More
